63
Views
1
CrossRef citations to date
0
Altmetric
Review

Aortic stenosis and the failing heart

&
Pages 25-31 | Published online: 10 Jan 2014

References

  • Stewart BF, Siscovick D, Lind BK et al. Clinical factors associated with calcific aortic valve disease. Cardiovascular Health Study. J. Am. Coll. Cardiol. 29(3), 630–634 (1997).
  • Lindroos M, Kupari M, Heikkila J, Tilvis R. Prevalence of aortic valve abnormalities in the elderly: an echocardiographic study of a random population sample. J. Am. Coll. Cardiol. 21(5), 1220–1225 (1993).
  • Freeman R, Otto C. Spectrum of calcific aortic valve disease: pathogenesis, disease progression, and treatment strategies. Circulation 111, 3316–3326 (2005).
  • Cosmi JE, Kort S, Tunick PA et al. The risk of the development of aortic stenosis in patients with ‘benign’ aortic valve thickening. Arch. Intern. Med. 162(20), 2345–2347 (2002).
  • Cowell SJ, Newby DE, Prescott RJ et al. A randomized trial of intensive lipid-lowering therapy in calcific aortic stenosis. N. Engl. J. Med. 352(23), 2389–2397 (2005).
  • Chockalingam A, Venkatesan S, Subramaniam T et al. Safety and efficacy of angiotensin-converting enzyme inhibitors in symptomatic severe aortic stenosis: Symptomatic Cardiac Obstruction-Pilot Study of Enalapril in Aortic Stenosis (SCOPE-AS). Am. Heart J. 147(4), E19 (2004).
  • Pellikka PA, Sarano ME, Nishimura RA et al. Outcome of 622 adults with asymptomatic, hemodynamically significant aortic stenosis during prolonged follow-up. Circulation 111, 3290–3295 (2005).
  • Ross J Jr, Braunwald E. Aortic stenosis. Circulation 38(1 Suppl.), 61–67 (1968).
  • Aronow WS, Ahn C, Kronzon I, Nanna M. Prognosis of congestive heart failure in patients aged > or = 62 years with unoperated severe valvular aortic stenosis. Am. J. Cardiol. 72(11), 846–848 (1993).
  • Horstkotte D, Loogen F. The natural history of aortic valve stenosis. Eur. Heart J. 9(Suppl. E), 57–64 (1988).
  • Kelly TA, Rothbart RM, Cooper CM et al. Comparison of outcome of asymptomatic to symptomatic patients older than 20 years of age with valvular aortic stenosis. Am. J. Cardiol. 61(1), 123–130 (1988).
  • Kennedy KD, Nishimura RA, Holmes DR Jr, Bailey KR. Natural history of moderate aortic stenosis. J. Am. Coll. Cardiol. 17(2), 313–319 (1991).
  • Otto CM, Burwash IG, Legget ME et al. Prospective study of asymptomatic valvular aortic stenosis. Clinical, echocardiographic, and exercise predictors of outcome. 95(9), 2262–2270 (1997).
  • Connolly HM, Oh JK, Orszulak TA et al. Aortic valve replacement for aortic stenosis with severe left ventricular dysfunction. Prognostic indicators. Circulation 95(10), 2395–2400 (1997).
  • Rispler S, Rinkevich D, Markiewicz W, Reisner SA. Missed diagnosis of severe symptomatic aortic stenosis. Am. J. Cardiol. 76(10), 728–730 (1995).
  • Bonow RO, Carabello B, de Leon AC Jr et al. Guidelines for the management of patients with valvular heart disease: executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients with Valvular Heart Disease). Circulation 98(18), 1949–1984 (1998).
  • Griffith MJ, Carey C, Coltart DJ, Jenkins BS, Webb-Peploe MM. Inaccuracies in using aortic valve gradients alone to grade severity of aortic stenosis. Br. Heart J. 62(5), 372–378 (1989).
  • Burwash IG, Pearlman AS, Kraft CD et al. Flow dependence of measures of aortic stenosis severity during exercise. J. Am. Coll. Cardiol. 24(5), 1342–1350 (1994).
  • Bermejo J, Garcia-Fernandez MA, Torrecilla EG et al. Effects of dobutamine on Doppler echocardiographic indexes of aortic stenosis. J. Am. Coll. Cardiol. 28(5), 1206–1213 (1996).
  • deFilippi CR, Willett DL, Brickner ME et al. Usefulness of dobutamine echocardiography in distinguishing severe from nonsevere valvular aortic stenosis in patients with depressed left ventricular function and low transvalvular gradients. Am. J. Cardiol. 75(2), 191–194 (1995).
  • Monin JL, Quere JP, Monchi M et al. Low-gradient aortic stenosis: operative risk stratification and predictors for long-term outcome: a multicenter study using dobutamine stress hemodynamics. Circulation 108(3), 319–324 (2003).
  • Monin JL, Monchi M, Gest V et al. Aortic stenosis with severe left ventricular dysfunction and low transvalvular pressure gradients: risk stratification by low-dose dobutamine echocardiography. J. Am. Coll. Cardiol. 37(8), 2101–2107 (2001).
  • Khot UN, Novaro GM, Popovic ZB et al. Nitroprusside in critically ill patients with left ventricular dysfunction and aortic stenosis.[see comment]. N. Engl. J. Med. 348(18), 1756–1763 (2003).
  • Moore P, Egito E, Mowrey H et al. Midterm results of balloon dilation of congenital aortic stenosis: predictors of success. J. Am. Coll. Cardiol. 27(5), 1257–1263 (1996).
  • Anonymous. Percutaneous balloon aortic valvuloplasty. Acute and 30-day follow-up results in 674 patients from the NHLBI Balloon Valvuloplasty Registry. Circulation 84(6), 2383–2397 (1991).
  • Otto CM, Mickel MC, Kennedy JW et al. Three-year outcome after balloon aortic valvuloplasty. Insights into prognosis of valvular aortic stenosis. Circulation 89(2), 642–650 (1994).
  • Safian RD, Warren SE, Berman AD et al. Improvement in symptoms and left ventricular performance after balloon aortic valvuloplasty in patients with aortic stenosis and depressed left ventricular ejection fraction. Circulation 78(5 Pt. 1), 1181–1191 (1988).
  • Moreno PR, Jang IK, Newell JB, Block PC, Palacios IF. The role of percutaneous aortic balloon valvuloplasty in patients with cardiogenic shock and critical aortic stenosis. J. Am. Coll. Cardiol. 23(5), 1071–1075 (1994).
  • Murphy ES, Lawson RM, Starr A, Rahimtoola SH. Severe aortic stenosis in patients 60 years of age or older: left ventricular function and 10-year survival after valve replacement. Circulation 64(2 Pt. 2), II184–188 (1981).
  • Schwarz F, Baumann P, Manthey J et al. The effect of aortic valve replacement on survival. Circulation 66(5), 1105–1110 (1982).
  • Blitz LR, Gorman M, Herrmann HC. Results of aortic valve replacement for aortic stenosis with relatively low transvalvular pressure gradients. Am. J. Cardiol. 81(3), 358–362 (1998).
  • Smith N, McAnulty JH, Rahimtoola SH. Severe aortic stenosis with impaired left ventricular function and clinical heart failure: results of valve replacement. Circulation 58(2), 255–264 (1978).
  • Powell DE, Tunick PA, Rosenzweig BP et al. Aortic valve replacement in patients with aortic stenosis and severe left ventricular dysfunction. Arch. Intern. Med. 160(9), 1337–1341 (2000).
  • Pereira JJ, Lauer MS, Bashir M et al. Survival after aortic valve replacement for severe aortic stenosis with low transvalvular gradients and severe left ventricular dysfunction. J. Am. Coll. Cardiol. 39(8), 1356–1363 (2002).
  • Schwammenthal E, Vered Z, Moshkowitz Y et al. Dobutamine echocardiography in patients with aortic stenosis and left ventricular dysfunction: predicting outcome as a function of management strategy. Chest 119(6), 1766–1777 (2001).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.